Clincosm LogoSign in Get a demo

recurrent oropharyngeal squamous cell carcinoma

Showing 1 - 12 of 12
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,

Recruiting
  • Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • +26 more
  • Biopsy
  • +5 more
  • Newark, Delaware
  • +52 more
Feb 2, 2023

Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Hypopharyngeal Squamous Cell Carcinoma, Recurrent Laryngeal Squamous

Recruiting
  • Recurrent Head and Neck Squamous Cell Carcinoma
  • +4 more
  • Birmingham, Alabama
  • +107 more
Aug 24, 2022

Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Hypopharyngeal Squamous Cell Carcinoma, Recurrent Laryngeal Squamous

Recruiting
  • Recurrent Head and Neck Squamous Cell Carcinoma
  • +5 more
  • Efineptakin alfa
  • San Francisco, California
    University of California San Francisco
Jul 7, 2022

Head and Neck Squamous Cell Carcinoma, Metastatic Head and Neck Squamous Cell Carcinoma, Metastatic Hypopharyngeal Squamous Cell

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +23 more
  • Biospecimen Collection
  • +2 more
  • Los Angeles, California
  • +1 more
Jul 7, 2022

Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Metastatic Head and Neck Squamous Cell Carcinoma,

Recruiting
  • Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • +24 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
May 18, 2022

Metastatic Head and Neck Squamous Cell Carcinoma, Metastatic Squamous Cell Carcinoma of the Hypopharynx, Metastatic Squamous

Active, not recruiting
  • Metastatic Head and Neck Squamous Cell Carcinoma
  • +9 more
  • Houston, Texas
    M D Anderson Cancer Center
Apr 27, 2022

Recurrent Colon Carcinoma, Recurrent Hypopharyngeal Squamous Cell Carcinoma, Recurrent Laryngeal Squamous Cell Carcinoma Trial

Completed
  • Recurrent Colon Carcinoma
  • +41 more
  • Cetuximab
  • +2 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Mar 12, 2020

FGFR Gene Amplification, FGFR1 Gene Amplification, FGFR2 Gene Amplification Trial in Chicago (BGJ398)

Terminated
Has Results
  • FGFR Gene Amplification
  • +9 more
  • Chicago, Illinois
    University of Chicago Comprehensive Cancer Center
Apr 9, 2019

Paranasal Sinus Squamous Cell Carcinoma, Recurrent Hypopharyngeal Squamous Cell Carcinoma, Recurrent Laryngeal Squamous Cell

Terminated
Has Results
  • Paranasal Sinus Squamous Cell Carcinoma
  • +16 more
  • Beverly Hills, California
  • +13 more
Mar 3, 2017

Recurrent Hypopharyngeal Squamous Cell Carcinoma, Recurrent Laryngeal Squamous Cell Carcinoma, Recurrent Laryngeal Verrucous

Completed
Has Results
  • Recurrent Hypopharyngeal Squamous Cell Carcinoma
  • +35 more
  • Cetuximab
  • +2 more
  • Scottsdale, Arizona
  • +23 more
Feb 23, 2017

Recurrent Hypopharyngeal Squamous Cell Carcinoma, Recurrent Laryngeal Squamous Cell Carcinoma, Recurrent Laryngeal Verrucous

Completed
Has Results
  • Recurrent Hypopharyngeal Squamous Cell Carcinoma
  • +30 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Atlanta, Georgia
  • +2 more
Sep 1, 2016

Recurrent Hypopharyngeal Squamous Cell Carcinoma, Recurrent Laryngeal Squamous Cell Carcinoma, Recurrent Laryngeal Verrucous

Completed
  • Recurrent Hypopharyngeal Squamous Cell Carcinoma
  • +22 more
  • Cediranib Maleate
  • Laboratory Biomarker Analysis
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Apr 14, 2015